Phenotypically, peptide-induced STAT3 inhibition decreased colony formation and reduced xenograft tumour growth [43], confirming that peptide inhibition of the Rac1–STAT3 axis could be of therapeutic utility. The gene discussed is RAC1; the disease is neoplasm.